|
FUT10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.60029999993905E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78600000011464E-07 |
| Normal-vs-Stage2 |
2.123400E-01 |
| Normal-vs-Stage3 |
1.249610E-01 |
| Normal-vs-Stage4 |
3.285400E-01 |
| Stage1-vs-Stage2 |
1.363960E-01 |
| Stage1-vs-Stage3 |
4.602200E-02 |
| Stage1-vs-Stage4 |
7.155800E-01 |
| Stage2-vs-Stage3 |
8.834800E-01 |
| Stage2-vs-Stage4 |
7.534200E-01 |
| Stage3-vs-Stage4 |
7.024400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.09059999989725E-07 |
| Normal-vs-AfricanAmerican |
8.608900E-04 |
| Normal-vs-Asian |
2.530400E-01 |
| Caucasian-vs-AfricanAmerican |
5.877400E-01 |
| Caucasian-vs-Asian |
9.436200E-01 |
| AfricanAmerican-vs-Asian |
8.097200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24429999637243E-08 |
| Normal-vs-Female |
1.589200E-01 |
| Male-vs-Female |
7.410800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.143800E-03 |
| Normal-vs-Extreme_Weight |
3.235600010143E-09 |
| Normal-vs-Obese |
8.355800E-03 |
| Normal-vs-Extreme_Obese |
1.199260E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.625200E-01 |
| Normal_Weight-vs-Obese |
5.889200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.389800E-01 |
| Extreme_Weight-vs-Obese |
2.064100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.576600E-01 |
| Obese-vs-Extreme_Obese |
2.592600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.295600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.033600E-04 |
| Normal-vs-Age(61-80Yrs) |
2.50880000107756E-08 |
| Normal-vs-Age(81-100Yrs) |
1.374160E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.321200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.510300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.349030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.261900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.788000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.661400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.36260000241862E-09 |
| Normal-VS-Type2 PRCC |
7.743700E-03 |
| Normal-VS-KIRP CIMP |
3.590400E-01 |
| Normal-VS-Unclassified PRCC |
2.760100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.126290E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.283900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.319600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.222200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.971600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.931900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.45560000000644E-06 |
| Normal-vs-N1 |
2.654000E-01 |
| Normal-vs-N2 |
6.060200E-01 |
| N0-vs-N1 |
1.020010E-01 |
| N0-vs-N2 |
2.507200E-01 |
| N1-vs-N2 |
2.511600E-01 |
|
|
